Search all trials

Find therapies in clinical trials near you – page 3

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Prostate cancer

Recruiting

Registered drugNo placebo

Study of xaluritamig plus abiraterone for men with metastatic castration-resistant prostate cancer who have not received chemotherapy

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Abiraterone Acetate

Contact Research Centre

Chronic inflammatory demyelinating polyradiculoneuropathy

Recruiting

Investigational

A Study of IMVT-1402 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy to Prevent Disease Relapse

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:IMEROPRUBART

Contact Research Centre

K-ras gene mutation+2

Recruiting

Registered drugNo placebo

Study of divarasib and pembrolizumab compared to standard chemotherapy in previously untreated KRAS G12C-mutated advanced non-small cell lung cancer

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Budesonide

Contact Research Centre

Dry age-related macular degeneration

Recruiting

Investigational

Study of ONL1204 eye injections to slow vision loss in patients with age-related macular degeneration and geographic atrophy

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:XELAFASLATIDE

Contact Research Centre

Systemic scleroderma+3

Recruiting

Registered drugNo placebo

Study of AlloNK and rituximab with cyclophosphamide and fludarabine in adults with relapsing rheumatoid arthritis, inflammatory myopathies, systemic sclerosis, or Sjögren's disease

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Squamous cell carcinoma of head and neck

Recruiting

Registered drug

Study of ficerafusp alfa and pembrolizumab as first treatment for patients with PD-L1-positive recurrent or metastatic head and neck cancer

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

IgA nephropathy

Recruiting

Registered drug

Study of felzartamab compared to placebo in adults with IgA nephropathy

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Codeine Phosphate

Contact Research Centre

Head and neck cancer

Recruiting

Registered drugNo placebo

Study of NBTXR3 and Cetuximab for Elderly Patients with Advanced Head and Neck Cancer Ineligible for Platinum Chemotherapy

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Cetuximab

Contact Research Centre

Systemic scleroderma

Recruiting

Registered drug

Study on the Effectiveness and Safety of Efgartigimod PH20 SC for Adults with Systemic Sclerosis

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Efgartigimod Alfa

Contact Research Centre

Immune thrombocytopenia

Recruiting

Registered drug

Study on the Effectiveness and Safety of Efgartigimod IV for Adults with Primary Immune Thrombocytopenia

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Efgartigimod Alfa

Contact Research Centre

Systemic scleroderma

Recruiting

Registered drug

Study on the Effectiveness and Safety of Ianalumab for Patients with Diffuse Cutaneous Systemic Sclerosis

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Emtricitabine

Contact Research Centre

Crohn's disease

Recruiting

Registered drug

Study on the Effectiveness and Safety of Vedolizumab and Upadacitinib in Adults with Moderate to Severe Crohn's Disease

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Upadacitinib

Contact Research Centre

Find therapies in clinical trials near you – page 3

145 trials match your criteria

Prostate cancer

Study of xaluritamig plus abiraterone for men with metastatic castration-resistant prostate cancer who have not received chemotherapy

Chronic inflammatory demyelinating polyradiculoneuropathy

A Study of IMVT-1402 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy to Prevent Disease Relapse

K-ras gene mutation+2

Study of divarasib and pembrolizumab compared to standard chemotherapy in previously untreated KRAS G12C-mutated advanced non-small cell lung cancer

Dry age-related macular degeneration

Study of ONL1204 eye injections to slow vision loss in patients with age-related macular degeneration and geographic atrophy

Systemic scleroderma+3

Study of AlloNK and rituximab with cyclophosphamide and fludarabine in adults with relapsing rheumatoid arthritis, inflammatory myopathies, systemic sclerosis, or Sjögren's disease

Squamous cell carcinoma of head and neck

Study of ficerafusp alfa and pembrolizumab as first treatment for patients with PD-L1-positive recurrent or metastatic head and neck cancer

IgA nephropathy

Study of felzartamab compared to placebo in adults with IgA nephropathy

Head and neck cancer

Study of NBTXR3 and Cetuximab for Elderly Patients with Advanced Head and Neck Cancer Ineligible for Platinum Chemotherapy

Systemic scleroderma

Study on the Effectiveness and Safety of Efgartigimod PH20 SC for Adults with Systemic Sclerosis

Immune thrombocytopenia

Study on the Effectiveness and Safety of Efgartigimod IV for Adults with Primary Immune Thrombocytopenia

Systemic scleroderma

Study on the Effectiveness and Safety of Ianalumab for Patients with Diffuse Cutaneous Systemic Sclerosis

Crohn's disease

Study on the Effectiveness and Safety of Vedolizumab and Upadacitinib in Adults with Moderate to Severe Crohn's Disease

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.